Deletion of Cd39/Entpd1 results in hepatic insulin resistance

Diabetes

Volumn 57, Issue 9, 2008, Pages 2311-2320

  Enjyoji, Keiichi ^a   Kotani, Ko ^a   Thukral, Chandrashekar ^a   Blumel, Benjamin ^a   Sun, Xiaofeng ^a   Wu, Yan ^a   Imai, Masato ^a   Friedman, David ^a   Csizmadia, Eva ^a   Bleibel, Wissam ^a   Kahn, Barbara B ^a   Robson, Simon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; GAMMA INTERFERON; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; NUCLEOTIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; APYRASE; CYTOKINE; INSULIN RECEPTOR SUBSTRATE 2 PROTEIN; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN; LEUKOCYTE ANTIGEN; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE DELETION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; BLOOD; BROWN ADIPOSE TISSUE; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENERGY METABOLISM; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; IMMUNOLOGY; LIVER; LIVER CELL; METABOLISM; MOUSE MUTANT; OXYGEN CONSUMPTION; PANCREAS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; ADIPOSE TISSUE, BROWN; ANIMALS; ANTIGENS, CD; APYRASE; BLOOD GLUCOSE; CELLS, CULTURED; CYTOKINES; ENERGY METABOLISM; GLUCOSE CLAMP TECHNIQUE; HEPATOCYTES; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PANCREAS; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 52749084491     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1265     Document Type: Article

References (42)

1. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC: Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358-404, 2006
2. Volonte C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G: P2 receptor web: complexity and fine-tuning. Pharmacol Ther 112:264-280, 2006
3. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS, 2nd, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD: Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017, 1999
4. Goepfert C, Sundberg C, Sevigny J, Enjyoji K, Hoshi T, Csizmadia E, Robson S: Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104:3109-3115, 2001
5. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, Takashima A: CD39 is the dominant Langerhans cell-associated ecto- NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8:358-365, 2002
6. Chevassus H, Roig A, Belloc C, Lajoix AD, Broca C, Manteghetti M, Petit P: P2Y receptor activation enhances insulin release from pancreatic beta- cells by triggering the cyclic AMP/protein kinase A pathway. Naunyn Schmiedebergs Arch Pharmacol 366:464-469, 2002
7. Fernandez-Alvarez J, Hillaire-Buys D, Loubatieres-Mariani MM, Gomis R, Petit P: P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 22:69-71, 2001
8. Poulsen CR, Bokvist K, Olsen HL, Hoy M, Capito K, Gilon P, Gromada J: Multiple sites of purinergic control of insulin secretion in mouse pancreatic p-cells. Diabetes 48:2171-2181, 1999
9. Kim MS, Lee J, Ha J, Kim SS, Kong Y, Cho YH, Baik HH, Kang I: ATP stimulates glucose transport through activation of P2 purinergic receptors in C(2)C(12) skeletal muscle cells. Arch Biochem Biophys 401:205-214, 2002
10. Solini A, Chiozzi P, Morelli A, Passaro A, Fellin R, Di Virgilio F: Defective P2Y purinergic receptor function: a possible novel mechanism for impaired glucose transport. J Cell Physiol 197:435-444, 2003
11. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F: The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877-3883, 2006
12. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257-1265, 2007
13. Robinson WP 3rd, Douillet CD, Milano PM, Boucher RC, Patterson C, Rich PB: ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway. Am J Physiol Heart Circ Physiol 290:H1988-H1996, 2006
14. Thevananther S, Sun H, Li D, Arjunan V, Awad SS, Wyllie S, Zimmerman TL, Goss JA, Karpen SJ: Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39:393-402, 2004
15. Friedman DJ, Rennke HG, Csizmadia E, Enjyoji K, Robson SC: The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes 56:2371-2379, 2007
16. Aguirre V, Uchida T, Yenush L, Davis R, White MF: The c-Jun NH(2)- terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000
17. Ishizuka T, Kajita K, Natsume Y, Kawai Y, Kanoh Y, Miura A, Ishizawa M, Uno Y, Morita H, Yasuda K: Protein kinase C (PKC) beta modulates serine phosphorylation of insulin receptor substrate-1 (IRS-1): effect of overexpression of PKCbeta on insulin signal transduction. Endocr Res 30:287-299, 2004
18. Kotani K, Peroni OD, Minokoshi Y, Boss O, Kahn BB: GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin Invest 114:1666-1675, 2004
19. Nagy TR, Clair AL: Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8:392-398, 2000
20. Harman AW, McCamish LE, Henry CA: Isolation of hepatocytes from postnatal mice. J Pharmacol Methods 17:157-163, 1987
21. Pedersen TA, Bereshchenko O, Garcia-Silva S, Ermakova O, Kurz E, Mandrup S, Porse BT, Nerlov C: Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo. EMBO J 26:1081-1093, 2007
22. Beldi G, Wu Y, Banz Y, Nowak M, Miller L, Enjyoji K, Yegutkin GG, Candinas D, Exley M, Robson SC: NKT cell dysfunction in CD39/Entpd1 null mice protects against concanavalin A-induced hepatitis. Hepatology, 2008. In press
23. Dranoff JA, Kruglov EA, Robson SC, Braun N, Zimmermann H, Sevigny J: The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36:1135-1144, 2002
24. Lee JH, Reed DR, Price RA: Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord 25:1471-1473, 2001
25. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG: Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54:2012-2018, 2005
26. Shimizu H, Oh IS, Okada S, Mori M: Leptin resistance and obesity. Endocr J 54:17-26, 2007
27. Cammisotto PG, Gelinas Y, Deshaies Y, Bukowiecki LJ: Regulation of leptin secretion from white adipocytes by insulin, glycolytic substrates, and amino acids. Ami. J Physiol Endocrinol Metab 289:E166-E171, 2005
28. Stefan C, Wera S, Stalmans W, Bollen M: The inhibition of the insulin receptor by the receptor protein PC-1 is not specific and results from the hydrolysis of ATP. Diabetes 45:980-983, 1996
29. Maddox BA, Goldfine ID: Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor a-subunit. Diabetes 49:13-19, 2000
30. Koike M, Kashiwagura T, Takeguchi N: Gluconeogenesis stimulated by extracellular ATP is triggered by the initial increase in the intracellular Ca2 + concentration of the periphery of hepatocytes. Biochem J 283:265-272, 1992
31. Emmett DS, Feranchak A, Kilic G, Puljak L, Miller B, Dolovcak S, McWilliams R, Doctor RB, Fitz JG: Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 47:698-705, 2008
32. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97, 2000
33. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL, Kahn CR: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111:1373-1380, 2003
34. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444:860-867, 2006
35. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 116:1793-1801, 2006
36. Scioscia M, Gumaa K, Kunjara S, Paine MA, Selvaggi LE, Rodeck CH, Rademacher TW: Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J Clin Endocrinol Metab 91:709-717, 2006
37. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T: Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory p-cell hyperplasia. Diabetes 49:1880-1889, 2000
38. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184, 2007
39. Inoue K, Hosoi J, Denda M: Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 127:362-371, 2007
40. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, Inoue K, Nakata Y: Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75:965-972, 2000
41. Hanley PJ, Musset B, Renigunta V, Limberg SH, Dalpke AH, Sus R, Heeg KM, Preisig-Muller R, Daut J: Extracellular ATP induces oscillations of intracellular Ca2 + and membrane potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad SciUSA 101:9479-9484, 2004
42. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, Robson SC: CD39 and control of cellular immune responses. Purinergic Signal 3:171-180, 2007